Additionally, SUP3-pretreated cDC1s that were pulsed with the melanoma cell-specific tumor antigen tyrosinase-related protein 2 (TRP2) demonstrated a robust antitumor response when adoptively transferred into B16F10 tumor-bearing mice (Fig. 3G). This evidence concerns the gene DCT and melanoma.